Get the Stockscreener App
4.46
28.90%
1.00
Pre-market:
4.48
0.02
+0.45%
908 Devices Inc stock is traded at $4.46, with a volume of 5.09M.
It is up +28.90% in the last 24 hours and up +75.59% over the past month.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
See More
Previous Close:
$3.46
Open:
$3.55
24h Volume:
5.09M
Relative Volume:
4.95
Market Cap:
$157.57M
Revenue:
$50.23M
Net Income/Loss:
$-36.40M
P/E Ratio:
-3.9469
EPS:
-1.13
Net Cash Flow:
$-27.10M
1W Performance:
+32.34%
1M Performance:
+75.59%
6M Performance:
+28.53%
1Y Performance:
-36.47%
1-Day Range:
$3.41
$4.80
1-Week Range:
$2.67
$4.80
52-Week Range:
$1.81
$7.56
908 Devices Inc Stock (MASS) Company Profile
Name
908 Devices Inc
Sector
Industry
Phone
978-729-4478
Address
645 SUMMER STREET, BOSTON
Compare MASS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASS
908 Devices Inc
|
4.46 | 157.57M | 50.23M | -36.40M | -27.10M | -1.13 |
|
ABT
Abbott Laboratories
|
130.28 | 225.95B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
96.42 | 142.29B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.84 | 138.83B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.51 | 117.34B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.51 | 40.28B | 5.72B | 4.17B | 259.90M | 6.97 |
908 Devices Inc Stock (MASS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-07-23 | Initiated | Stephens | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jan-12-21 | Initiated | Cowen | Outperform |
| Jan-12-21 | Initiated | SVB Leerink | Outperform |
| Jan-12-21 | Initiated | Stifel | Buy |
| Jan-12-21 | Initiated | William Blair | Outperform |
View All
908 Devices Inc Stock (MASS) Latest News
908 Devices gets $1.7M order from Ministry of Health of Ukraine - MSN
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device - 01Net
908 Devices climbs on $1.7 mln order from Ukraine - TradingView
908 Devices secures $1.7 million order from Ukraine - Investing.com India
908 Devices secures $1.7 million order from Ukraine By Investing.com - Investing.com South Africa
908 Devices Receives $1.7M Order From The Ministry Of Health Of Ukraine For Its Handheld Mass Spec Device - Marketscreener.com
What Is The Outlook For 908 Devices Inc (NASDAQ: MASS) Like For Short-Term? - Stocks Register
908 Devices: Strategic Divestiture and Strong Financial Performance Drive Buy Rating - TipRanks
Repligen Corporation’s Acquisition of Bioprocessing PAT Device Portfolio from 908 Devices - Global Legal Chronicle
Weiss Ratings Reaffirms Sell (E+) Rating for 908 Devices (NASDAQ:MASS) - Defense World
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates - MSN
908 Devices Inc. SEC 10-K Report - TradingView
Repligen buying 908 Devices’ Bioprocess Analytics portfolio - BioWorld Online
908 Devices Makes Key Divestiture (Rating Upgrade) (NASDAQ:MASS) - Seeking Alpha
908 Devices earnings missed by $0.33, revenue fell short of estimates - Investing.com Australia
Stifel maintains Buy on 908 Devices, target steady at $6 By Investing.com - Investing.com Canada
Stifel maintains Buy on 908 Devices, target steady at $6 - Investing.com India
908 Devices Inc. Reports Strategic Transformation and Growth - MSN
Repligen lays down $70m to buy analytics tech from 908 Devices - BioProcess Insider
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices - Genetic Engineering & Biotechnology News
908 Devices Inc.'s (NASDAQ:MASS) 55% Jump Shows Its Popularity With Investors - Simply Wall St
908 Devices Inc (MASS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance
908 Devices stock surges on strategic transformation and growth outlook By Investing.com - Investing.com South Africa
908 Devices stock surges on strategic transformation and growth outlook - Investing.com
Repligen Corporation acquired the assets related to bioprocessing analytics portfolio of 908 Devices Inc. for $56 million. - Marketscreener.com
908 Devices jumps as Repligen buys bioprocessing analytics portfolio - MSN
Earnings call transcript: 908 Devices Q4 2024 revenue up 31%, stock surges - Investing.com India
MASS’s 2023 Market Dance: Up 66.78% – Time to Invest? - The InvestChronicle
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth - Benzinga India
Strategic Divestment and Focus on Growth Propel 908 Devices to a Buy Rating - TipRanks
908 Devices reports Q4 EPS (56c), consensus (35c) - TipRanks
908 Devices Inc. reports results for the quarter ended December 31Earnings Summary - TradingView
Repligen Corporation acquired Bioprocessing Analytics Portfolio from 908 Devices Inc. for $70 million. - Marketscreener.com
Repligen’s Strategic Acquisition of 908 Devices’ Bioprocessing Assets Boosts Buy Rating - TipRanks
MASSive Gains for 908 Devices: Is This Stock Turning Around? - RagingBull
908 Devices Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
Investor presentation (03/04/2025 00: 00 - Marketscreener.com
Repligen Acquires 908 Devices’ Bioprocess Analytics Portfolio - Contract Pharma
908 DEVICES Earnings Results: $MASS Reports Quarterly Earnings - Nasdaq
908 Devices stock jumps on Repligen deal (RGEN:NASDAQ) - Seeking Alpha
Repligen acquires 908 Devices’ desktop bioprocessing tech - Investing.com India
908 Devices stock soars on divestiture and revenue growth By Investing.com - Investing.com Canada
908 Devices sells desktop assets, sees revenue growth By Investing.com - Investing.com South Africa
908 Devices stock soars on divestiture and revenue growth - Investing.com
Repligen Buys 908 Devices' Desktop Portfolio for $70 Million -March 04, 2025 at 08:07 am EST - Marketscreener.com
908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
908 Devices sells desktop assets, sees revenue growth - Investing.com
BRIEF-908 Devices Q4 EPS USD -0.56 - TradingView
Repligen purchases 908 Devices’ bioprocessng analytics portfolio for $70M - TipRanks
How Repligen's $70M Bioprocessing Analytics Acquisition Transforms Its Market Position - StockTitan
908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - BioSpace
908 Devices Inc Stock (MASS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.08%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):